12264 related articles for article (PubMed ID: 11668469)
81. Metastatic uveal melanoma. A morphologic and immunohistochemical analysis.
Luyten GP; Mooy CM; Post J; Jensen OA; Luider TM; de Jong PT
Cancer; 1996 Nov; 78(9):1967-71. PubMed ID: 8909318
[TBL] [Abstract][Full Text] [Related]
82. Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas.
Viray H; Bradley WR; Schalper KA; Rimm DL; Gould Rothberg BE
Arch Pathol Lab Med; 2013 Aug; 137(8):1063-73. PubMed ID: 23899062
[TBL] [Abstract][Full Text] [Related]
83. Comparative immunoreactivity of CD-68 and HMB-45 in malignant melanoma, neural tumors and nevi.
Shah IA; Gani OS; Wheler L
Pathol Res Pract; 1997; 193(7):497-502. PubMed ID: 9342756
[TBL] [Abstract][Full Text] [Related]
84. Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update.
Ordóñez NG
Hum Pathol; 2014 Feb; 45(2):191-205. PubMed ID: 23648379
[TBL] [Abstract][Full Text] [Related]
85. KBA.62: a useful marker for primary and metastatic melanomas.
Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
[TBL] [Abstract][Full Text] [Related]
86. [Malignant melanoma and the role of the paradoxal protein Microphthalmia transcription factor].
Denat L; Larue L
Bull Cancer; 2007 Jan; 94(1):81-92. PubMed ID: 17237008
[TBL] [Abstract][Full Text] [Related]
87. Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study.
Makhlouf HR; Ishak KG; Shekar R; Sesterhenn IA; Young DY; Fanburg-Smith JC
Arch Pathol Lab Med; 2002 Jan; 126(1):49-55. PubMed ID: 11800647
[TBL] [Abstract][Full Text] [Related]
88. Heterogenous S-100B protein expression patterns in malignant melanoma and association with serum protein levels.
Bánfalvi T; Udvarhelyi N; Orosz Z; Gergye M; Gilde K; Tímár J
Oncology; 2003; 64(4):374-9. PubMed ID: 12759535
[TBL] [Abstract][Full Text] [Related]
89. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
Mirecka J; Korabiowska M; Schauer A
Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
[TBL] [Abstract][Full Text] [Related]
90. S100 protein and HMB-45 negative "rhabdoid" malignant melanoma: a totally dedifferentiated malignant melanoma?
Laskin WB; Knittel DR; Frame JN
Am J Clin Pathol; 1995 Jun; 103(6):772-3. PubMed ID: 7785665
[No Abstract] [Full Text] [Related]
91. Cutaneous melanoma with myxoid features: twelve cases with differential diagnosis.
Hitchcock MG; McCalmont TH; White WL
Am J Surg Pathol; 1999 Dec; 23(12):1506-13. PubMed ID: 10584704
[TBL] [Abstract][Full Text] [Related]
92. Immunostaining of human melanomas by a monoclonal antibody to B700 mouse melanoma antigen.
Xu X; Azumi N; Skelton HG; Hearing VJ; Gersten DM
Eur J Cancer; 1996 Jan; 32A(1):168-73. PubMed ID: 8695227
[TBL] [Abstract][Full Text] [Related]
93. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study.
Argenyi ZB; Cain C; Bromley C; Nguyen AV; Abraham AA; Kerschmann R; LeBoit PE
Am J Dermatopathol; 1994 Jun; 16(3):233-40. PubMed ID: 7943629
[TBL] [Abstract][Full Text] [Related]
94. Can SOX-10 or KBA.62 Replace S100 Protein in Immunohistochemical Evaluation of Sentinel Lymph Nodes for Metastatic Melanoma?
Vrotsos E; Alexis J
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):26-9. PubMed ID: 25611246
[TBL] [Abstract][Full Text] [Related]
95. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: Further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas.
Radfar A; Stefanato CM; Ghosn S; Bhawan J
Am J Dermatopathol; 2006 Apr; 28(2):162-7. PubMed ID: 16625082
[TBL] [Abstract][Full Text] [Related]
96. HMB-45 recognizes stimulated melanocytes.
Smoller BR; McNutt NS; Hsu A
J Cutan Pathol; 1989 Apr; 16(2):49-53. PubMed ID: 2668355
[TBL] [Abstract][Full Text] [Related]
97. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
98. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases.
Anstey A; Cerio R; Ramnarain N; Orchard G; Smith N; Jones EW
Am J Dermatopathol; 1994 Feb; 16(1):14-22. PubMed ID: 7512798
[TBL] [Abstract][Full Text] [Related]
99. Metastatic malignant melanoma resembling malignant peripheral nerve sheath tumor: report of 16 cases.
King R; Busam K; Rosai J
Am J Surg Pathol; 1999 Dec; 23(12):1499-505. PubMed ID: 10584703
[TBL] [Abstract][Full Text] [Related]
100. Melanoma cell heterogeneity. A study of two monoclonal antibodies compared with S-100 protein in paraffin sections.
Duray PH; Palazzo J; Gown AM; Ohuchi N
Cancer; 1988 Jun; 61(12):2460-8. PubMed ID: 3365669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
